Abstract
12-O-Tetradecanoylphorbol-13-acetate (TPA) is a potent tumor promoter with wide ranging, diverse, and sometimes opposite cellular effects. Using oligonucleotide microarray analysis, we have identified a novel gene that is upregulated following treatment with TPA in the pancreatic cancer cell line CD18. Real-time PCR validated the microarray results in CD18 and HeLa cells, and showed that upregulation of the gene is time- and concentration-dependent. In silico analysis showed the gene product to be a single-pass transmembrane protein of 217 residues that is localized to the endoplasmic reticulum, thus the name TPA induced trans-membrane protein (TTMP). A luciferase reporter assay demonstrated that upregulation of TTMP by TPA is triggered at the promoter level.
Original language | English |
---|---|
Pages (from-to) | 755-764 |
Number of pages | 10 |
Journal | Biochemical and Biophysical Research Communications |
Volume | 329 |
Issue number | 2 |
DOIs | |
Publication status | Published - Apr 8 2005 |
Externally published | Yes |
Keywords
- 12-O-Tetradecanoylphorbol-13-acetate
- In silico analysis
- Luciferase assay
- Microarray
- Novel protein
- Protein kinase C
- Real-time PCR
- TTMP
ASJC Scopus subject areas
- Biophysics
- Biochemistry
- Molecular Biology
- Cell Biology